Take care of your cells
Alvéole develops innovative tools to control the cell microenvironment, thus allowing biologists to control the development and proliferation of living cells in culture.
Alvéole was founded in 2010 by three researchers from CNRS1-2-3 in collaboration with Quattrocento, a “creator of companies” in the life sciences field that enables academic researchers to transform their inventions into commercial products.
Vincent Studer (a microfluidics specialist), Maxime Dahan (a cell imaging specialist) and Jean-Christophe Galas (a specialist in nanostructures), have collaborated since 2008 to develop tools for research in cell biology. In 2010, support from Quattrocento made it possible for them to create Alvéole.
In 2016, after 6 years of industrial development, Alvéole launched its first product, PRIMO, a photopatterning device that allows biologists to create protein patterns for cell-based assays with applications in cell biology and medical research.
The company, currently undergoing expansion, now comprises 12 people, 5 of whom are devoted to research and development.
Alvéole’s research, development and industrialization scientists use the latest innovations in cell imaging, microfluidics and nanotechnologies. They actively collaborate with several research laboratories, including the Interdisciplinary Institute for Neuroscience (IINS) in Bordeaux.
Alvéole is recruiting. Discoveries, innovations and science are a genuine passion for you… And for us too! If you like taking on challenges, working in project mode, and want to join a rapidly growing company, send your CV and cover letter to Romuald Vally.
SLAS (Society for Laboratory Automation and Screening) is a global community of more than 18,000 scientists—from academia, government and industry—collectively focused on leveraging the power of technology to achieve scientific objectives. 320 exhibitors participated in the 2016 SLAS conference in San Diego. During the event, the new products have been assessed for their innovative nature and their impact in the field of laboratory techniques. Primo wins the 2016 New Product Award.
Alvéole was a prize winner at the Worldwide Innovation Challenge for its CellForLife project in the individualised medicine category. This project aims to develop a complete offering with a handling platform and a miniaturised device to control stem cell differentiation, in order to develop personalised treatments for patients suffering from genetic diseases. As part of their research into Rett syndrome, researchers at the Cochin Institute use the Alvéole tools to understand the disease and develop specific therapies.